IMMUNOTHERAPY
Clinical trials for IMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test combo therapy to fight spreading cancer
Disease control CompletedThis study looked at the safety and effects of combining two cancer treatments: immunotherapy drugs and palliative radiation. It involved 42 adults with advanced cancer that had spread, who were already receiving or about to start immunotherapy. The goal was to see if giving thes…
Matched conditions: IMMUNOTHERAPY
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope to avoid colostomy bags: triple therapy tested for rectal cancer
Disease control CompletedThis study tested whether adding immunotherapy to standard chemotherapy and radiation before surgery could improve outcomes for people with a specific type of ultra-low rectal cancer. The goal was to shrink tumors enough so surgeons could avoid removing the anus, allowing patient…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE2, PHASE3 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
First human test: can your own immune cells fight advanced cancer?
Disease control CompletedThis early-stage study tested the safety of a personalized immunotherapy for people with advanced solid tumors. Doctors collected immune cells from patients' tumors, grew more of them in a lab, and then reinfused them back into 43 participants to see if they could fight the cance…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to shrink tumors before lung cancer surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug serplulimab to standard chemotherapy, given both before and after surgery, could help people with operable non-small cell lung cancer. The goal was to see if this combination could shrink tumors more effectively before surge…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New strategy tested to overcome resistance to melanoma immunotherapy
Disease control CompletedThis study tested a two-step approach for patients with advanced melanoma that did not respond to standard immunotherapy. First, patients received a chemotherapy drug (DTIC). Then, they tried immunotherapy again. The goal was to see if the chemotherapy could 'reset' the tumor and…
Matched conditions: IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Tracking the Heart's response to powerful cancer treatment
Knowledge-focused CompletedThis study aims to understand how CAR-T cell therapy, a treatment for certain blood cancers, affects heart function. Researchers followed 44 adults before and after receiving the therapy, checking their hearts with ultrasound scans and blood tests over six months. The goal is to …
Matched conditions: IMMUNOTHERAPY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC